Most recently, HNRNPL was reported to facilitate the formation of circular Rho GTPase activating protein 35 (ARHGAP35) to promote cancer progression by interacting with the transcription factor TFII-I [229]. The gene discussed is ARHGAP35; the disease is cancer.